DrugPatentWatch Database Preview
Ramipril - Generic Drug Details
What are the generic drug sources for ramipril and what is the scope of ramipril patent protection?
Ramipril
is the generic ingredient in two branded drugs marketed by King Pharms Llc, Accord Hlthcare, Actavis Elizabeth, Apotex, Aurobindo Pharma Ltd, Chartwell Molecular, Cipla, Dr Reddys Labs Ltd, Lupin, Ranbaxy Labs Ltd, Teva Pharms, Watson Labs, West-ward Pharms Int, Yaopharma Co Ltd, Zydus Pharms Usa, King Pfizer, Apotex Inc, Mylan Pharms Inc, and Zydus Pharms Usa Inc, and is included in nineteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.There are nineteen drug master file entries for ramipril. Thirty-four suppliers are listed for this compound.
Summary for ramipril
| US Patents: | 1 |
| Tradenames: | 2 |
| Applicants: | 19 |
| NDAs: | 19 |
| Drug Master File Entries: | 19 |
| Suppliers / Packagers: | 34 |
| Bulk Api Vendors: | 73 |
| Clinical Trials: | 134 |
| Patent Applications: | 6,551 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ramipril |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ramipril |
| DailyMed Link: | ramipril at DailyMed |
Pharmacology for ramipril
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for ramipril
Synonyms for ramipril
| (2 S ,3 aS ,6 aS )-1[( S )-N-[( S )-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester |
| (2 S ,3 aS,6 aS)-1[(S)-N-[(S)-1-Carboxy-3-phenylpropyl] alanyl] octahydrocyclopenta [ b ]pyrrole-2-carboxylic acid, 1-ethyl ester |
| (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2s,3as,6as)-1-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-octahydrocyclopenta[b]p |
| (2S,3AS,6AS)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID |
| (2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester |
| (2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure |
| (2S,3AS,6AS)-1-[(2S)-2-([(2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL]AMINO)PROPANOYL]-OCTAHYDROCYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID |
| (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[d]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| (2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name) |
| (2s,3as,6as)-1-[(s)-2-((s)-1-ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b] |
| (2S,3AS,6AS)-1-[(S)-2-((S)-1-ETHOXYCARBONYL-3-PHENYL-PROPYLAMINO)-PROPIONYL]-OCTAHYDRO-CYCLOPENTA[B]PYRROLE-2-CARBOXYLIC ACID |
| (2s,3as,6as)-1((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic |
| (2S,3AS,6AS)-1((S)-N-((S)-1-CARBOXY-3-PHENYLPROPYL)ALANYL)OCTAHYDROCYCLOPENTA(B)PYRROLE-2-CARBOXYLIC ACID 1-ETHYL ESTER |
| [2s,3as,6as]-1-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopen |
| [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]pyrrole-2-carboxylic acid(Ramipril) |
| 126613-39-6 |
| 333R195 |
| 4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylic acid |
| 87333-19-5 |
| 88094-EP2270011A1 |
| 88094-EP2272841A1 |
| 88094-EP2277879A1 |
| 88094-EP2287165A2 |
| 88094-EP2287166A2 |
| 88094-EP2292620A2 |
| 88094-EP2298742A1 |
| 88094-EP2298776A1 |
| 88094-EP2298779A1 |
| 88094-EP2301923A1 |
| 88094-EP2301931A1 |
| 88094-EP2301936A1 |
| 88094-EP2305648A1 |
| AB0008490 |
| AB00698339_09 |
| AB00698339_10 |
| AB00698339-07 |
| AB00698339-08 |
| AB07503 |
| AB2000297 |
| AC-1347 |
| AC1NSFPR |
| Acovil |
| AK163187 |
| AKOS005622534 |
| Almirall Brand of Ramipril |
| Altace |
| Altace (TN) |
| AM015032 |
| AN-15038 |
| Astra Brand of Ramipril |
| AstraZeneca Brand of Ramipril |
| Aventis Brand of Ramipril |
| Aventis Pharma Brand of Ramipril |
| B2208 |
| BBL033964 |
| BC205360 |
| BDBM50084681 |
| BIDD:GT0803 |
| Bio-0651 |
| BSPBio_003347 |
| C23H32N2O5 |
| Carasel |
| Cardace |
| CAS-87333-19-5 |
| CCG-100833 |
| CHEBI:8774 |
| CHEMBL1168 |
| CPD000466386 |
| CS-2270 |
| CTK8G2889 |
| Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,6abeta))- |
| Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S(1(R*(R*)),2alpha,3abeta,6abeta))- |
| D00421 |
| D01STB |
| DB00178 |
| Delix |
| DR002533 |
| DSSTox_CID_3551 |
| DSSTox_GSID_23551 |
| DSSTox_RID_77077 |
| DTXSID8023551 |
| GTPL6339 |
| HDACQVRGBOVJII-JBDAPHQKSA-N |
| HMS2051E04 |
| HMS2090L11 |
| HMS2093M10 |
| HMS2231M05 |
| HMS3259J07 |
| HOE 498 |
| Hoe-498 |
| HOE498 |
| Hoechst Brand of Ramipril |
| HY-B0279 |
| Hypren |
| Hytren |
| J90014 |
| KBio2_002504 |
| KBio2_005072 |
| KBio2_007640 |
| KBio3_002849 |
| KBioGR_001858 |
| KBioSS_002512 |
| KS-1103 |
| L35JN3I7SJ |
| Lostapres |
| LS-58199 |
| MCULE-5386328912 |
| MFCD00865775 |
| MLS000759523 |
| MLS001216547 |
| MLS001423965 |
| MolPort-001-736-571 |
| Monarch Brand of Ramipril |
| N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid |
| Naprix |
| NC00083 |
| NC00627 |
| NCGC00016955-01 |
| NCGC00178127-01 |
| NCGC00178127-02 |
| NE42859 |
| NPD2431 |
| NSC-758933 |
| NSC758933 |
| Pharmakon1600-01505214 |
| Pramace |
| Pramace (discontinued) |
| Prilace |
| Promed Brand of Ramipril |
| Quark |
| Ramace |
| Ramipril (Altace) |
| Ramipril (USP/INN) |
| Ramipril [USAN:INN:BAN] |
| Ramipril [USAN:USP:INN:BAN] |
| Ramipril, >=98% (HPLC) |
| Ramipril, British Pharmacopoeia (BP) Reference Standard |
| Ramipril, European Pharmacopoeia (EP) Reference Standard |
| Ramipril, pharmaceutical secondary standard; traceable to USP, PhEur, BP |
| Ramipril, United States Pharmacopeia (USP) Reference Standard |
| Ramiprilum |
| Ramiprilum [Latin] |
| Ramipro |
| Ramipro, Tritace, Altace, Prilace, Ramipril |
| Ramipro;Tritace;Prilace;Altace |
| s1793 |
| SAM001246757 |
| SAM002699899 |
| SBI-0206728.P001 |
| SC-17348 |
| SCHEMBL16059 |
| SMR000466386 |
| Spectrum_001958 |
| SPECTRUM1505214 |
| Spectrum3_001794 |
| Spectrum4_001269 |
| Spectrum5_001721 |
| SR-05000001908 |
| SR-05000001908-2 |
| STK801937 |
| Tox21_110708 |
| Tox21_110708_1 |
| Triatec |
| Tritace |
| Tritace (TN) |
| UNII-L35JN3I7SJ |
| Unipril |
| Vesdil |
| Z1946144927 |
| Zabien |
| ZINC3798757 |
US Patents and Regulatory Information for ramipril
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecular | RAMIPRIL | ramipril | CAPSULE;ORAL | 078745-003 | Jun 18, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Cipla | RAMIPRIL | ramipril | CAPSULE;ORAL | 077004-001 | Aug 7, 2008 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Apotex Inc | RAMIPRIL | ramipril | TABLET;ORAL | 091069-002 | Dec 2, 2015 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for ramipril
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-002 | Feb 27, 2007 | ➤ Sign Up | ➤ Sign Up |
| King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-001 | Feb 27, 2007 | ➤ Sign Up | ➤ Sign Up |
| King Pharms Llc | ALTACE | ramipril | CAPSULE;ORAL | 019901-004 | Jan 28, 1991 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for ramipril
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1216038 | ➤ Sign Up |
| European Patent Office | 1611886 | ➤ Sign Up |
| South Africa | 200201470 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for ramipril
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 80030 | Netherlands | ➤ Sign Up | PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919 |
| C0001 | Belgium | ➤ Sign Up | PRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919 |
| C/GB98/047 | United Kingdom | ➤ Sign Up | PRODUCT NAME: COMBINATIONS OF RAMIPRIL, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND FELODIPINE, OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: SE 13596 19970919; SE 13597 19970919; UK 00017/0402 19980825; UK 00017/0403 19980825 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: